BCL6B expression in hepatocellular carcinoma and its efficacy in the inhibition of liver damage and fibrogenesis

B cell CLL/lymphoma 6 member B (BCL6B) is expressed in many normal tissues but expressed at very low levels in cancer tissues. It was reported that BCL6B inhibits hepatocellular carcinoma (HCC) metastases, but the exact role of BCL6B in HCC remains to be investigated. BCL6B expression was significan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Wang, Weilin, Huang, Pengfei, Wu, Panyisha, Kong, Rong, Xu, Jiang, Zhang, Lufei, Yang, Qifan, Xie, Qingsong, Zhang, Linshi, Zhou, Xiaohu, Chen, Linghui, Xie, Haiyang, Zhou, Lin, Zheng, Shusen
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2015
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4653002/
https://ncbi.nlm.nih.gov/pubmed/25970780
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi